Mid Day stocks

build your financial model here www.blattistics.com

Stocks rebounding.

Stocks are still lower but they’re off their worst levels of the session. Profit taking all day is the main reason.
Each sell off has brought out buyers. The averages have been establishing higher lows with each sell off and subsequent buying, setting up what could be a late day move towards positive territory. The Dow is down 70 to 9,250, the NASDAQ is down 25.50 to 1,985.85, and the S&P is down 6.75 to 998.90.

MOVERS
On2 Technologies (ONT) up 50% after announcing that it will be acquired by Google (GOOG)

Onyxx Pharmaceuticals (ONXX) is down over 14% after announcing concurent offerings of 4M shares of common stock and $200M in convertible senior notes.

INOVIO Biomedical (AMEX:INO) (INO) is still up in the $2.56 up over 25% on 15milion shares.

If you think inflation is coming back go long TBT. I plan to

Unusual options trading activity in Pfizer Inc. (NYSE: PFE).

As of 11:00 AM EST we have seen some 47,000 PFE AUG $13 CALLS traded today alone versus a prior open interest of a mere 120 contracts.  Out in September expiration, we have seen 10,500 of the SEPT $11 Calls trade versus a prior open interest of 10 contracts.

July 20 stocks on the move pre market

NYSE:CIT shares spiked 90% in pre open trade as investors breathed a sigh of relief that bankruptcy appeared off the table for the time being.

CIT is said to be paying 10.5% for the funds, which should enable the troubled small- and medium-sized business lender to meet obligations on about $1 billion in debt coming due in August, the Wall Street journal reported on Monday.

GR:NYSE Goodrich signs long-term agreement with Alp Aviation for F-35 Lightning II landing gear components and assemblies. The agreement covers deliveries.

Cisco: Upgrade  breakout shares were upgraded to Outperform at Credit Suisse, with a $25 price target. Friday shares broke out  and now are up 2.1% in the pre-market.  high at the
$20.35 area, which now becomes support. Resistance levels to watch as potential upside objectives are at $21.18,  $22.48.

Citigroup upgraded Allergan to Buy from Hold to reflect increased estimates for Botox and its belief Latisse guidance looks conservative. The firm raised its target on shares to $57 from $45.

Jefferies upgraded Texas Instruments to Hold from Underperform after channel checks indicated business is strengthening. Jefferies believes Texas Instruments’ September quarter guidance will come in better than expected and raised its target on shares to 23 from $16.